The efficacy of various vaccination schedules was evaluated in 17-day-old Pekin geese utilizing an experimental inactivated entire virus vaccine based mostly on the H5N9 A/hen/Italy/22A/98 isolate (H5N9-It) and/or a fowlpox recombinant (vFP-H5) expressing an artificial HA gene from an Asian H5N1 isolate (A/hen/Indonesia/7/2003).
Full safety towards scientific indicators and shedding was induced by the totally different vaccination schemes. Nonetheless, the broadest antibody response and the bottom antibody improve after problem have been noticed within the group of geese whose immune system was primed with the fowlpox vectored vaccine and boosted with the inactivated vaccine, suggesting that this prime-boost technique induced optimum immunity towards H5N1 and minimal viral replication after problem in geese. As well as, this prime-boost vaccination scheme was proven to be immunogenic in 1-day-old ducklings.
Danger elements and traits of H5N1 Extremely Pathogenic Avian Influenza (HPAI) post-vaccination outbreaks.
Extremely pathogenic avian influenza (HPAI) virus H5N1 is now endemic in South-East Asia however HPAI management strategies differ between international locations. A widespread HPAI vaccination marketing campaign that began on the finish of 2005 in Viet Nam resulted within the cessation of poultry and human circumstances, however in 2006/2007 extreme HPAI outbreaks re-emerged.
On this research we investigated the sample of this primary post-vaccination epidemic in southern Viet Nam figuring out a spatio-temporal cluster of outbreak prevalence and estimating spatially smoothed incidence charges of HPAI. Spatial threat elements related to HPAprevalence have been recognized.
Medium-level poultry density resulted in an elevated outbreak threat (Odds ratio (OR) = 5.4, 95% confidence interval (CI): 1.6-18.9) but in addition climate-vegetation elements performed an necessary position: medium-level normalised distinction vegetation indices throughout the wet season from Could to October have been related to greater threat of HPAI outbreaks (OR = 3.7, 95% CI: 1.7-8.1), in all probability as a result of temporal flooding might need offered appropriate circumstances for the re-emergence of HPAI by increasing the virus distribution within the surroundings and by enlarging areas of potential contacts between home waterfowl and wild birds.
However, a number of agricultural manufacturing elements, comparable to candy potatoes yield, elevated buffalo density, in addition to elevated electrical energy provide have been related to decreased threat of HPAI outbreaks. This illustrates that preventive management measures for HPAI ought to embrace a promotion of low-risk agricultural administration practices in addition to enchancment of the infrastructure in village households. Improved HPAI vaccination efforts and protection ought to give attention to medium poultry density areas and on the pre-monsoon time interval.
Investigation of the organic indicator for vaccine efficacy towards extremely pathogenic avian influenza (HPAI) H5N1 virus problem in mice and ferrets.
To research the organic indicator for vaccine efficacy towards HPAI H5N1 virus problem of various clades, two inactivated whole-virus H5N1 vaccines containing the hemagglutinin (HA) and neuraminidase (NA) genes of both clade 2.2 A/EM/Korea/W149/06 (RgKoreaW149/06 x PR8) or clade 2.5 A/Ck/Korea/ES/03 (RgKoreaES223N/03XPR8) virus within the background of A/PR/8/34 (H1N1) have been generated by reverse genetics.
Administration of the vaccines (2-dose 1.77, 3.5, 7.5 or 15microg of HA) elicited excessive HI titers in a dose-dependent method. Mice immunized with RgKoreaW149/06 x PR8 have been fully shielded from problem towards wild-type A/EM/Korea/W149/06 with out scientific indicators of an infection. RgKoreaES223N/03XPR8 couldn’t shield mice at 1.77microg whereas all immunized ferrets have been fully protected. Two-dose (7.5microg) vaccinated mice (HI titer>> or =320) and triple dose (7.5 microg) vaccinated ferrets with RgKoreaES223N/03xPR8 (HI titer>> or =640) protected vaccine recipients from mortality, inhibited nasal virus shedding and restricted influenza virus tropism.
Thus, these vaccines offered cross-protectivity in each fashions. Extra importantly, these outcomes collectively advised a constructive correlation between vaccine-induced HI titers and inhibition of virus shedding together with block of viral proliferation in main organs towards a heterologous HPAI H5N1 virus. Though creating applied sciences or strategies that can allow the discount of administration dose/frequency stays to be resolved, our research demonstrated a substantial organic marker >> or =640 HI titer) for full safety of the vaccinated hosts that would present a preliminary foundation for the evaluation of full immunization.
Mucosal immunity induced by adenovirus-based H5N1 HPAI vaccine confers safety towards a deadly H5N2 avian influenza virus problem.
Improvement of efficient vaccines towards extremely pathogenic avian influenza (HPAI) H5N1 viruses is a worldwide public well being precedence. Contemplating the problem in predicting HPAI H5N1 pandemic strains, one technique used of their design consists of the event of formulations with the capability of eliciting broad cross-protective immunity towards a number of viral antigens.
To this finish we constructed a replication-defective recombinant adenovirus-based avian influenza virus vaccine (rAdv-AI) expressing the codon-optimized M2eX-HA-hCD40L and the M1-M2 fusion genes from HPAI H5N1 human isolate. Though there have been no vital variations within the systemic immune responses noticed between the intramuscular prime-intramuscular increase routine (IM/IM) and the intranasal prime-intramuscular increase routine (IN/IM), IN/IM induced stronger CD8(+) T cell and antibody responses at mucosal websites than the IM/IM vaccination, leading to more practical safety towards deadly H5N2 avian influenza (AI) virus problem.
Rabbit Ig fraction |
|||
| 31R-1018 | Fitzgerald | 10 mg | EUR 136.8 |
|
Description: Rabbit Ig fraction control or blocking reagent |
|||
Rabbit Ig fraction |
|||
| 31R-1042 | Fitzgerald | 10 mg | EUR 136.8 |
|
Description: Purified Rabbit Ig fraction for use as a control or blocking reagent |
|||
Goat Anti-Rabbit Secondary Antibody, Biotin Conjugated |
|||
| A12001 | EpiGentek |
|
|
Pyruvate Kinase antibody (IgG fraction) |
|||
| 20C-CR7017GP | Fitzgerald | 1 mL | EUR 282 |
|
Description: Goat polyclonal Pyruvate Kinase antibody (IgG fraction) |
|||
Pyruvate Kinase antibody (IgG fraction) |
|||
| 20R-PG010 | Fitzgerald | 1 ml | EUR 282 |
|
Description: Goat polyclonal Pyruvate Kinase antibody (IgG fraction) |
|||
Ibrutinib drug-Human IgG Conjugate |
|||
| IBT17-IgG | Alpha Diagnostics | 100 ug | EUR 634.8 |
Human PAI-1/tPA AssayMax ELISA Kit |
|||
| EP1105-1 | AssayPro | 96 Well Plate | EUR 500.4 |
Sheep Anti-Human Plasminogen Activator Inhibitor 1 (PAI-1) IgG, pure |
|||
| PAI21-A | Alpha Diagnostics | 100 ul | EUR 489.6 |
Monoclonal Anti-Human Plasminogen Activator Inhibitor 1 (PAI-1) IgG, pure |
|||
| PAI22-M | Alpha Diagnostics | 100 ul | EUR 578.4 |
Polyclonal Goat anti-GST α-form |
|||
| GST-ANTI-1 | Detroit R&D | 50 uL | EUR 336 |
Anti-PAI-1 antibody |
|||
| PAab06114 | Lifescience Market | 100 ug | EUR 463.2 |
anti- PAI-1 antibody |
|||
| FNab06114 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against PAI-1 |
|||
Anti-PAI-1 antibody |
|||
| STJ94934 | St John's Laboratory | 200 µl | EUR 236.4 |
|
Description: Rabbit polyclonal to PAI-1. |
|||
Anti-PAI-1 antibody |
|||
| STJ16100781 | St John's Laboratory | 100 µg | EUR 724.8 |
Goat anti-Rabbit IgG SecondaryAntibody (peroxidase conjugated) |
|||
| E0L3012-1 | EnoGene | 500ul | EUR 153.6 |
Rabbit anti-goat IgG(H+L)-HRP |
|||
| E22NG02-1 | EnoGene | 100ul | EUR 411.6 |
unconjugated Rabbit Anti-human IgG (H+L) secondary antibody |
|||
| BA1041-1 | BosterBio | 1mg | EUR 121.2 |
Anti-Human IgG |
|||
| DB-173-1 | DB Biotech | 1 ml | EUR 735.6 |
|
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated |
|||
Anti-Human IgG |
|||
| DB-174-1 | DB Biotech | 1 ml | EUR 735.6 |
|
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated |
|||
Plasminogen Activator Inhibitor 1 (PAI-1), hexapeptide, Human |
|||
| SP-55196-1 | Alpha Diagnostics | 0.5 mg | EUR 169.2 |
Rabbit PAI 1 ELISA Kit |
|||
| ERTP0035 | Abclonal | 96Tests | EUR 625.2 |
Human Plasminogen Activator Inhibitor-1 (PAI-1) AssayMax ELISA Kit |
|||
| EP1100-1 | AssayPro | 96 Well Plate | EUR 500.4 |
Rabbit Immunoglobulin G (IgG) ELISA Kit |
|||
| DLR-IgG-Rb-48T | DL Develop | 48T | EUR 404.4 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rabbit Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
|||
Rabbit Immunoglobulin G (IgG) ELISA Kit |
|||
| DLR-IgG-Rb-96T | DL Develop | 96T | EUR 511.2 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rabbit Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
|||
Rabbit Immunoglobulin G (IgG) ELISA Kit |
|||
| RDR-IgG-Rb-48Tests | Reddot Biotech | 48 Tests | EUR 397.2 |
Rabbit Immunoglobulin G (IgG) ELISA Kit |
|||
| RDR-IgG-Rb-96Tests | Reddot Biotech | 96 Tests | EUR 541.2 |
CF633 Rabbit anti-human IgG(H+L), highly cross-adsorbed |
|||
| 20066-1 | Biotium | 50uL | EUR 150 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
Biotin Conjugated Rabbit Anti-human IgG (H+L) secondary antibody |
|||
| BA1020-1 | BosterBio | 1ml | EUR 157.2 |
HRP Conjugated Rabbit Anti-human IgG (H+L) secondary antibody |
|||
| BA1070-1 | BosterBio | 1ml | EUR 279.6 |
TRITC Conjugated Rabbit Anti-human IgG (H+L) secondary antibody |
|||
| BA1092-1 | BosterBio | 1ml | EUR 400.8 |
FITC Conjugated Rabbit Anti-human IgG (H+L) secondary antibody |
|||
| BA1114-1 | BosterBio | 1mL | EUR 242.4 |
Anti-Mouse IgG Rabbit Monoclonal Antibody, Clone#RM104 |
|||
| M04575-1 | BosterBio | 100ug | EUR 450 |
|
Description: Anti-Mouse IgG Rabbit Monoclonal Antibody, Clone#RM104 tested in WB (nonreduced), IP, ICC, IHC, FC, ELISA , reactive to Mouse |
|||
Rabbit anti-Spodoptera frugiperda/Baculovirus (Sf9) Host Cell Proteins (HCPs) IgG (Low molecular weight fraction, soluble fraction affinity pure) |
|||
| 730-145-11A | Alpha Diagnostics | 100 ug | EUR 548.4 |
Rabbit anti-Spodoptera frugiperda/Baculovirus (Sf9) Host Cell Proteins IgG (HCPs) (High molecular weight fraction, soluble fraction, affinity pure) |
|||
| 730-145-12A | Alpha Diagnostics | 100 ug | EUR 548.4 |
Rabbit anti Human IgG |
|||
| 40C-CB0943 | Fitzgerald | 1 mg | EUR 298.8 |
|
Description: Rabbit anti Human IgG secondary antibody |
|||
Rabbit anti Human IgG |
|||
| 40C-CB0950 | Fitzgerald | 5 mg | EUR 457.2 |
|
Description: Rabbit anti Human IgG secondary antibody |
|||
Rabbit anti Human IgG |
|||
| 40C-CB0971 | Fitzgerald | 2 mg | EUR 386.4 |
|
Description: Rabbit anti Human IgG secondary antibody |
|||
Rabbit Anti Human IgG |
|||
| E61I00101 | EnoGene | 100ug | EUR 411.6 |
CF555 goat anti-rabbit IgG(H+L), 2mg/mL |
|||
| 20033-1 | Biotium | 50uL | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF647 goat anti-rabbit IgG(H+L), 2mg/mL |
|||
| 20043-1 | Biotium | 50uL | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
unconjugated Goat Anti-rabbit IgG (H+L) secondary antibody |
|||
| BA1039-1 | BosterBio | 1mg | EUR 121.2 |
unconjugated Rabbit Anti-goat IgG (H+L) secondary antibody |
|||
| BA1040-1 | BosterBio | 1mg | EUR 121.2 |
unconjugated Rabbit Anti-rat IgG (H+L) secondary antibody |
|||
| BA1042-1 | BosterBio | 1mg | EUR 121.2 |
unconjugated Rabbit Anti-mouse IgG (H+L) secondary antibody |
|||
| BA1048-1 | BosterBio | 1mg | EUR 121.2 |
HRP Conjugated anti-Rabbit IgG Super Vision Assay Kit |
|||
| SV0002-1 | BosterBio | 10ml/kit | EUR 242.4 |
Rabbit plasminogen activator inhibitor 1, PAI-1 ELISA Kit |
|||
| 1-CSB-E06978Rb | Cusabio |
|
|
|
Description: Quantitativecompetitive ELISA kit for measuring Rabbit plasminogen activator inhibitor 1, PAI-1 in samples from serum, plasma, cell culture supernates, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
Rabbit PAI ELISA Kit |
|||
| ERTP0600 | Abclonal | 96Tests | EUR 625.2 |
Rabbit Anti-Human IgG (Fc) IgG, unlabeled |
|||
| 10119-R | Alpha Diagnostics | 0.5 mg | EUR 169.2 |
Recombinant Human PAI-1 |
|||
| P0142 | FN Test | 100ug | EUR 626.83 |
|
Description: Recombinant Human protein for PAI-1 |
|||
Human Recombinant PAI-1 |
|||
| 6377-100 | Biovision | each | EUR 483.6 |
Rabbit IgG Control Sera |
|||
| 20009-1-200 | Alpha Diagnostics | 0.5 ml | EUR 123.6 |
Rabbit IgG-Agarose conjugate |
|||
| 20009-AS-1 | Alpha Diagnostics | 0.5 ml | EUR 196.8 |
CF568 goat anti-rabbit IgG(H+L), 2 mg/mL |
|||
| 20102-1 | Biotium | 50uL | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF568 rabbit anti-goat IgG(H+L), 2 mg/mL |
|||
| 20107-1 | Biotium | 50uL | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF594 goat anti-rabbit IgG(H+L), 2 mg/mL |
|||
| 20112-1 | Biotium | 50uL | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF594 rabbit anti-goat IgG(H+L), 2 mg/mL |
|||
| 20117-1 | Biotium | 50uL | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF633 goat anti-rabbit IgG(H+L), 2 mg/mL |
|||
| 20122-1 | Biotium | 50uL | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF633 rabbit anti-goat IgG(H+L), 2 mg/mL |
|||
| 20128-1 | Biotium | 50uL | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF350 goat anti-rabbit IgG(H+L), 2 mg/mL |
|||
| 20141-1 | Biotium | 50uL | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF405M goat anti-rabbit IgG(H+L), 2 mg/mL |
|||
| 20181-1 | Biotium | 50uL | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
Biotin goat anti-rabbit IgG(H+L), 2 mg/mL |
|||
| 20185-1 | Biotium | 50uL | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF640R goat anti-rabbit IgG(H+L), 2 mg/mL |
|||
| 20202-1 | Biotium | 50uL | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF488A chicken anti-rabbit IgG(H+L), 2 mg/mL |
|||
| 20209-1 | Biotium | 50uL | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF594 chicken anti-rabbit IgG(H+L), 2 mg/mL |
|||
| 20223-1 | Biotium | 50uL | EUR 150 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF633 chicken anti-rabbit IgG(H+L), 2 mg/mL |
|||
| 20224-1 | Biotium | 50uL | EUR 150 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF543 goat anti-rabbit IgG(H+L), 2 mg/mL |
|||
| 20309-1 | Biotium | 50uL | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF543 rabbit anti-goat IgG(H+L), 2 mg/mL |
|||
| 20315-1 | Biotium | 50uL | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF488A goat anti-rabbit IgG(H+L), 2 mg/mL |
|||
| 20012-1 | Biotium | 50uL | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF488A rabbit anti-goat IgG(H+L), 2 mg/mL |
|||
| 20021-1 | Biotium | 50uL | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF555 rabbit anti-goat IgG(H+L), 2 mg/mL |
|||
| 20031-1 | Biotium | 50uL | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF647 rabbit anti-goat IgG(H+L), 2 mg/mL |
|||
| 20049-1 | Biotium | 50uL | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF660C goat anti-rabbit IgG(H+L), 2 mg/mL |
|||
| 20053-1 | Biotium | 50uL | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF660R goat anti-rabbit IgG(H+L), 2 mg/mL |
|||
| 20055-1 | Biotium | 50uL | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF680 rabbit anti-goat IgG(H+L), 2 mg/mL |
|||
| 20068-1 | Biotium | 50uL | EUR 158.4 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF750 goat anti-rabbit IgG(H+L), 2 mg/mL |
|||
| 20073-1 | Biotium | 50uL | EUR 158.4 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF405S goat anti-rabbit IgG(H+L), 2 mg/mL |
|||
| 20082-1 | Biotium | 50ul | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50ul |
|||
CF640R rabbit anti-goat IgG(H+L), 2 mg/mL |
|||
| 20090-1 | Biotium | 50uL | EUR 144 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
Biotin Conjugated Goat Anti-rabbit IgG (H+L) secondary antibody |
|||
| BA1003-1 | BosterBio | 1ml | EUR 157.2 |
Biotin Conjugated Rabbit Anti-rat IgG (H+L) secondary antibody |
|||
| BA1005-1 | BosterBio | 1ml | EUR 157.2 |
Biotin Conjugated Rabbit Anti-goat IgG (H+L) secondary antibody |
|||
| BA1006-1 | BosterBio | 1ml | EUR 157.2 |
HRP Conjugated Goat Anti-rabbit IgG (H+L) secondary antibody |
|||
| BA1054-1 | BosterBio | 1ml | EUR 279.6 |
HRP Conjugated Rabbit Anti-rat IgG (H+L) secondary antibody |
|||
| BA1058-1 | BosterBio | 1ml | EUR 279.6 |
HRP Conjugated Rabbit Anti-goat IgG (H+L) secondary antibody |
|||
| BA1060-1 | BosterBio | 1ml | EUR 279.6 |
TRITC Conjugated Goat Anti-rabbit IgG (H+L) secondary antibody |
|||
| BA1090-1 | BosterBio | 1ml | EUR 400.8 |
TRITC Conjugated Rabbit Anti-goat IgG (H+L) secondary antibody |
|||
| BA1091-1 | BosterBio | 1ml | EUR 400.8 |
FITC Conjugated Goat Anti-rabbit IgG (H+L) secondary antibody |
|||
| BA1105-1 | BosterBio | 1mL | EUR 242.4 |
FITC Conjugated Rabbit Anti-rat IgG (H+L) secondary antibody |
|||
| BA1108-1 | BosterBio | 1mL | EUR 279.6 |
FITC Conjugated Rabbit Anti-goat IgG (H+L) secondary antibody |
|||
| BA1110-1 | BosterBio | 1mL | EUR 242.4 |
DyLight®488 Conjugated Goat Anti-rabbit IgG (H+L) |
|||
| BA1127-1 | BosterBio | 1ml | EUR 400.8 |
DyLight®594 Conjugated Goat Anti-rabbit IgG (H+L) |
|||
| BA1142-1 | BosterBio | 1ml | EUR 400.8 |
Biotin Conjugated Mouse Anti-rabbit IgG (H+L) secondary antibody |
|||
| BM2004-1 | BosterBio | 1ml | EUR 412.8 |
Rabbit anti Human IgG (FITC) |
|||
| 43C-CB0944 | Fitzgerald | 1 mg | EUR 373.2 |
|
Description: Rabbit anti Human IgG secondary antibody (FITC) |
|||
Rabbit anti Human IgG (rhodamine) |
|||
| 43C-CB0945 | Fitzgerald | 1 mg | EUR 417.6 |
|
Description: Rabbit anti Human IgG secondary antibody (Rhodamine) |
|||
Rabbit anti Human IgG (biotin) |
|||
| 43C-CB0947 | Fitzgerald | 1 mg | EUR 408 |
|
Description: Rabbit anti Human IgG secondary antibody (biotin) |
|||
Rabbit anti Human IgG (HRP) |
|||
| 43C-CB0948 | Fitzgerald | 1 mg | EUR 500.4 |
|
Description: Rabbit anti Human IgG secondary antibody (HRP) |
|||
Rabbit anti Human IgG (FITC) |
|||
| 43C-CB0951 | Fitzgerald | 2 mg | EUR 327.6 |
|
Description: Rabbit anti Human IgG secondary antibody (FITC) |
|||
Rabbit anti Human IgG (rhodamine) |
|||
| 43C-CB0952 | Fitzgerald | 2 mg | EUR 333.6 |
|
Description: Rabbit anti Human IgG secondary antibody (Rhodamine) |
|||
Rabbit anti Human IgG (biotin) |
|||
| 43C-CB0954 | Fitzgerald | 2 mg | EUR 408 |
|
Description: Rabbit anti Human IgG secondary antibody (biotin) |
|||
Rabbit anti Human IgG (HRP) |
|||
| 43C-CB0955 | Fitzgerald | 2 mg | EUR 433.2 |
|
Description: Rabbit anti Human IgG secondary antibody (HRP) |
|||
Rabbit anti Human IgG (FITC) |
|||
| 43C-CB0965 | Fitzgerald | 2 mg | EUR 349.2 |
|
Description: Rabbit anti Human IgG secondary antibody (FITC) |
|||
Rabbit anti Human IgG (rhodamine) |
|||
| 43C-CB0966 | Fitzgerald | 2 mg | EUR 349.2 |
|
Description: Rabbit anti Human IgG secondary antibody (Rhodamine) |
|||
Rabbit anti Human IgG (biotin) |
|||
| 43C-CB0968 | Fitzgerald | 2 mg | EUR 430.8 |
|
Description: Rabbit anti Human IgG secondary antibody (biotin) |
|||
Rabbit anti Human IgG (HRP) |
|||
| 43C-CB0969 | Fitzgerald | 2 mg | EUR 442.8 |
|
Description: Rabbit anti Human IgG secondary antibody (HRP) |
|||
Rabbit Anti-Human IgG FC |
|||
| C020221-1mg | Unibiotest | 1mg | EUR 322.8 |
Rabbit Anti-Human IgG FC |
|||
| C020221-50mg | Unibiotest | 50mg | EUR 7218 |
Rabbit Anti Human IgG-Biotin |
|||
| E61I00102 | EnoGene | 1mg | EUR 598.8 |
Rabbit Anti Human IgG-HRP |
|||
| E61I00103 | EnoGene | 1mg | EUR 598.8 |
Rabbit Anti Human IgG-FITC |
|||
| E61I00104 | EnoGene | 1mg | EUR 733.2 |
CF488A Rabbit anti-human IgG(H+L), highly cross-adsorbed, 2 mg/mL |
|||
| 20071-1 | Biotium | 50uL | EUR 164.4 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
CF594 Rabbit anti-human IgG(H+L), highly cross-adsorbed, 2 mg/mL |
|||
| 20072-1 | Biotium | 50uL | EUR 164.4 |
|
Description: Minimum order quantity: 1 unit of 50uL |
|||
Rabbit anti-Saccharomyces Cerevisiae Host Cell Proteins (HCPs) IgG (Low molecular weight fraction, affinity pure) |
|||
| 760-160-11A | Alpha Diagnostics | 100 ug | EUR 548.4 |
Rabbit anti-Saccharomyces Cerevisiae Host Cell Proteins (HCPs) IgG (High molecular weight fraction, affinity pure) |
|||
| 760-160-12A | Alpha Diagnostics | 100 ug | EUR 548.4 |
Rabbit Anti-HIV-1 gp41 IgG |
|||
| AB-16010 | Alpha Diagnostics | 1 ml | EUR 416.4 |
Rabbit Anti-Pasteurella multocida IgG ELISA Kit, 96 tests |
|||
| AE-310800-1 | Alpha Diagnostics | 1 kit | EUR 680.4 |
Nori® Rabbit Pai-1 ELISA Kit |
|||
| GR144022 | Genorise Scientific | 96-well | EUR 553.2 |
PAI-1 Peptide |
|||
| 45-142P | ProSci | 0.1 mg | EUR 405.6 |
|
Description: (IN) PAI-1 / SERPINE1 Peptide |
|||
